Notably, IGF1R (insulin-like growth factor 1 receptor) and PDGFRB (platelet-derived growth factor receptor, beta polypeptide) were upregulated in p53 minus scenarios, which together with FGF2 changes highlighted growth factor mediated signalling pathways as important factor contributing to survival of these tumours. The gene discussed is TP53; the disease is neoplasm.